6092 · EnBio Holdings,Inc · Financials
Market Cap
6.16B JPY
Shares
8.12M
Volume · Nov 13
11.9K
Avg daily vol (3M)
25.8K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
12.63B
+18.4%
FY2026
Net Income
265M
-41.5%
FY2026
Gross Margin
29.2%
+4.3pp
FY2026
Operating Margin
12.82%
+5pp
FY2026
Operating Cash Flow
1.17B
+5224.1%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 12.63B | 10.67B | 9.58B | 8.12B | 8.99B |
| JPY | 8.94B | 8.01B | 7.09B | 5.36B | 6.56B |
| JPY | 3.69B | 2.65B | 2.48B | 2.76B | 2.43B |
| JPY | 1.62B | 839.45M | 815.16M | 1.36B | 1.23B |
| JPY | 915M | 702.12M | 1.07B | 1.23B | 1.1B |
| JPY | 663M | 281.9M | 326.25M | 437.61M | 392.41M |
| JPY | 265M | 452.69M | 708.76M | 812.06M | 654.06M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2026: 242.87M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.